On June 22, 2018 Soribada Inc. (KOSDAQ:A053110) closed the transaction. The transaction included participation from Human Bio Fund 1 Co., Ltd. for KRW 4,000,000,000 and Lee, Donghoon for KRW 1,000,000,000. The bonds are issued at par and carry a zero coupon rate. The bonds have yield to maturity of 6% and would mature on June 22, 2021. The bonds are fully convertible into 3,130,216 shares of the company at a fixed conversion price of KRW 2,396 between the periods of June 22, 2019 to May 22, 2021.